Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MECTA is a healthcare medical-device company focused on electroconvulsive therapy (ECT) systems used by licensed clinicians and hospitals. The company operates under the name MECTA LLC, formerly MECTA Corporation, and markets commercial ECT devices and related software rather than a traditional drug pipeline. Its current portfolio includes the MECTA Sigma ECT device and EMR software, while older spECTrum models have been discontinued. MECTA serves psychiatric and hospital providers in the neuromodulation market and appears to remain commercially active following a 2021 Chapter 11 bankruptcy process involving MECTA Corporation and affiliate Balance Point LLC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MECTA.